DEA Notice on Veranova Bulk Manufacturing Application
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The notice opens a comment period on Veranova, L.P.'s application to register as a bulk manufacturer of many controlled substances, including fentanyl, morphine, oxycodone, methamphetamine, psilocybin, cannabis-related substances, and other listed drug classes. The practical effect is limited to DEA-regulated manufacturers and applicants. Registered bulk manufacturers of the affected substances can submit objections, comments, or hearing requests by August 14, 2026. Veranova says it plans to manufacture these substances as internal intermediates and for sale to customers, and the registration would not authorize other activities.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Opens a DEA comment period on Veranova's application to become a bulk manufacturer of listed controlled substances
- Allows affected registered bulk manufacturers and applicants to file comments, objections, or hearing requests by August 14, 2026
- Limits the proposed registration to bulk manufacturing for internal intermediates and customer sales
Obligations
What this law requires
Registered bulk manufacturers of the affected controlled substance basic classes, and applicants for such registration, may submit electronic comments or objections to DEA regarding Veranova, L.P.'s proposed bulk manufacturer registration by August 14, 2026.
Any eligible person submitting comments on the application must submit them electronically through the Federal eRulemaking Portal at Regulations.gov and follow the portal's online instructions.
Registered bulk manufacturers of the affected controlled substance basic classes, and applicants for such registration, may file a written request for a hearing on Veranova, L.P.'s application by August 14, 2026.